93 related articles for article (PubMed ID: 11106241)
1. BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers.
Shih HA; Nathanson KL; Seal S; Collins N; Stratton MR; Rebbeck TR; Weber BL
Clin Cancer Res; 2000 Nov; 6(11):4259-64. PubMed ID: 11106241
[TBL] [Abstract][Full Text] [Related]
2. Molecular Research and Treatment of Breast Cancer 2.0.
Kawiak A
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612742
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 and BRCA2 mutations and breast cancer.
Narod SA; Salmena L
Discov Med; 2011 Nov; 12(66):445-53. PubMed ID: 22127115
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Kwan E; Jack E; Vesprini DJ; Kuperstein G; Abrahamson JL; Fan I; Wong B; Narod SA
Am J Hum Genet; 2001 Mar; 68(3):700-10. PubMed ID: 11179017
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.
Capalbo C; Ricevuto E; Vestri A; Ristori E; Sidoni T; Buffone O; Adamo B; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A; Giannini G
Ann Oncol; 2006 Jun; 17 Suppl 7():vii34-40. PubMed ID: 16760289
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility Genes Associated with Multiple Primary Cancers.
Lu M; Zhang X; Chu Q; Chen Y; Zhang P
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136334
[TBL] [Abstract][Full Text] [Related]
7. p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer.
Bai F; Liu X; Zhang X; Mao Z; Wen H; Ma J; Pei XH
Cell Cycle; 2023 Jul; 22(13):1637-1653. PubMed ID: 37345432
[TBL] [Abstract][Full Text] [Related]
8. Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer.
Sun X; Liu K; Lu S; He W; Du Z
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358874
[TBL] [Abstract][Full Text] [Related]
9. BRCA mutations and gastrointestinal cancers: When to expect the unexpected?
Maccaroni E; Giampieri R; Lenci E; Scortichini L; Bianchi F; Belvederesi L; Brugiati C; Pagliaretta S; Ambrosini E; Berardi R
World J Clin Oncol; 2021 Jul; 12(7):565-580. PubMed ID: 34367929
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience.
Moore A; Bar Y; Maurice-Dror C; Finkel I; Goldvaser H; Dudnik E; Goldstein DA; Gordon N; Billan S; Gutfeld O; Wolf I; Popovtzer A
Medicine (Baltimore); 2021 Jun; 100(25):e26388. PubMed ID: 34160418
[TBL] [Abstract][Full Text] [Related]
11. Should the BCRA1/2-mutations healthy carriers be valid candidates for hematopoietic stem cell donation?
Fresa A; Sica S
Hered Cancer Clin Pract; 2021 Apr; 19(1):22. PubMed ID: 33794974
[TBL] [Abstract][Full Text] [Related]
12. Analysis, identification and visualization of subgroups in genomics.
Völkel G; Laban S; Fürstberger A; Kühlwein SD; Ikonomi N; Hoffman TK; Brunner C; Neuberg DS; Gaidzik V; Döhner H; Kraus JM; Kestler HA
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32954413
[TBL] [Abstract][Full Text] [Related]
13. Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers.
Maxwell KN; Wenz BM; Kulkarni A; Wubbenhorst B; D'Andrea K; Weathers B; Goodman N; Vijai J; Lilyquist J; Hart SN; Slavin TP; Schrader KA; Ravichandran V; Thomas T; Hu C; Robson ME; Peterlongo P; Bonanni B; Ford JM; Garber JE; Neuhausen SL; Shah PD; Bradbury AR; DeMichele AM; Offit K; Weitzel JN; Couch FJ; Domchek SM; Nathanson KL
JCO Precis Oncol; 2020; 4():. PubMed ID: 32954205
[TBL] [Abstract][Full Text] [Related]
14. Overview of the genetic basis toward early detection of breast cancer.
De Silva S; Tennekoon KH; Karunanayake EH
Breast Cancer (Dove Med Press); 2019; 11():71-80. PubMed ID: 30718964
[TBL] [Abstract][Full Text] [Related]
15. The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans.
Kim H; Choi DH; Park W; Im YH; Ahn JS; Park YH; Nam SJ; Kim SW; Lee JE; Yu JH; Lee SK; Jung BY
Hered Cancer Clin Pract; 2019; 17():1. PubMed ID: 30622657
[TBL] [Abstract][Full Text] [Related]
16. Association of a novel point mutation in MSH2 gene with familial multiple primary cancers.
Hu H; Li H; Jiao F; Han T; Zhuo M; Cui J; Li Y; Wang L
J Hematol Oncol; 2017 Oct; 10(1):158. PubMed ID: 28974240
[TBL] [Abstract][Full Text] [Related]
17. Skin cancer risk in BRCA1/2 mutation carriers.
Gumaste PV; Penn LA; Cymerman RM; Kirchhoff T; Polsky D; McLellan B
Br J Dermatol; 2015 Jun; 172(6):1498-1506. PubMed ID: 25524463
[TBL] [Abstract][Full Text] [Related]
18. Novel Germline Mutation of BRCA1 Gene in a 56-Year-Old Woman with Breast Cancer, Ovarian Cancer, and Diffuse Large B-Cell Lymphoma.
Kim HS; Lee SW; Choi YJ; Shin SW; Kim YH; Cho MS; Lee SN; Park KH
Cancer Res Treat; 2015 Jul; 47(3):534-8. PubMed ID: 25483746
[TBL] [Abstract][Full Text] [Related]
19. Associations between BRCA Mutations in High-Risk Breast Cancer Patients and Familial Cancers Other than Breast or Ovary.
Noh JM; Choi DH; Baek H; Nam SJ; Lee JE; Kim JW; Ki CS; Park W; Huh SJ
J Breast Cancer; 2012 Sep; 15(3):283-7. PubMed ID: 23091540
[TBL] [Abstract][Full Text] [Related]
20. BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity.
Juwle A; Saranath D
Med Oncol; 2012 Dec; 29(5):3272-81. PubMed ID: 22752604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
